Tumor recurrence was inversely correlated to Tg expression as it was found in 6 out of 17 (35%), 9 out of 39 (23%), 9 out of 48 (18%), and 15 out of 140 (10%) of patients with tumors expressing Tg in 0–25%, 26–50%, 51–75% and 76–100% of tumors cells (p = 0.025), respectively. This evidence concerns the gene TG and neoplasm.